Home › Funds › Bellevue Group AG › INSM

Bellevue Group AG position in INSM

INSMED INC · Health Care

Bellevue Group AG reported holding 1,393,418 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$148.6M, representing 3.13% of its reported portfolio and ranking #7 among its reported holdings. Bellevue Group AG has disclosed INSM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.39M sh
Reported value held$148.57M
Portfolio Weight3.13%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's INSM position evolved

Bellevue Group AG first disclosed a stake in INSM in Q3 2023 at 3,162,735 shares (US$79.9M). The position peaked in Q2 2026 at 1,393,418 shares, worth US$148.6M. Across 12 filings, Bellevue Group AG increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,393,418 shares valued at US$148.6M — an increase of 1,383,384 shares quarter over quarter.. Notable position changes include a 52% trim in Q2 2024 (shares rose 8% over the following quarter), a 75% trim in Q3 2025 (shares rose 24% over the following quarter), a 13787% increase in Q2 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.16M $79.86M New
Q4 2023 2.29M $71.00M Reduce
Q1 2024 2.14M $58.11M Reduce
Q2 2024 1.02M $68.45M Reduce
Q3 2024 525.43K $38.36M Reduce
Q4 2024 258.48K $17.85M Reduce
Q1 2025 150.55K $11.49M Reduce
Q2 2025 81.40K $8.19M Reduce
Q3 2025 20.25K $2.92M Reduce
Q4 2025 13.91K $2.42M Reduce
Q1 2026 10.03K $1.64M Reduce
Q2 2026 1.39M $148.57M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 39 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has Bellevue Group AG held INSM?

Bellevue Group AG has disclosed INSM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Bellevue Group AG's current position in INSM?

As of Q2 2026, Bellevue Group AG holds 1.39M shares of INSM (INSMED INC), valued at $148.57M, representing 3.13% of its reported portfolio and ranking #7.

Has Bellevue Group AG been buying or selling INSM?

In the latest 13F filing (Q2 2026), Bellevue Group AG increased its position in INSM. The position peaked in Q2 2026 at 1.39M shares.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.